|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 410 JPY | +2.50% |
|
+5.40% | -12.02% |
| Apr. 22 | Lull in Geopolitical Tensions Lifts Asian Stock Markets | MT |
| Apr. 17 | Jefferies Adjusts Sumitomo Pharma’s Price Target to 420 Yen From 520 Yen, Keeps at Hold | MT |
Sumitomo Pharma Co., Ltd. reported earnings results for the half year ended September 30, 2023. For the half year, the company reported sales was JPY 152,642 million compared to JPY 319,289 million a year ago. Net loss was JPY 67,741 million compared to JPY 7,283 million a year ago.
Basic loss per share from continuing operations was JPY 170.51 compared to JPY 18.33 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -12.02% | 1.03B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
SUMITOMO PHARMA CO., LTD. 
